2KB-15856-91235 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-10
Dose 1 — Janssen/Johnson & Johnson
2021-11-24
Dose 2 — Pfizer-BioNTech
2021-12-13
Registered in v-safe
2021-12-13
Survey response — day 14, dose 2
MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Tested positive for Covid

MedDRA releases: 2024-11 · check-in free text available
2021-12-13
Report sent to call center — day 14, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-14
Call 1 — Left Voicemail
2021-12-15
Survey response — day 21, dose 2
MedDRA: COVID-19, Fatigue, Headache — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Still have COVID. Extreme fatigue. Headaches.

MedDRA releases: 2024-11 · check-in free text available
2021-12-15
Report sent to call center — day 21, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-16
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-10	Janssen/Johnson & Johnson	No
2	2021-11-24	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-12-13	Unsuccessful
2021-12-15	Unsuccessful

Free text

Release 10 — day 14, dose 2

2021-12-13

Symptoms: Tested positive for Covid

Release 10 — day 21, dose 2

2021-12-15

Symptoms: Still have COVID. Extreme fatigue. Headaches.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	SARS-CoV-2 test positive	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release